• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Analysis: Drug Costs Become Bigger Issue in Cancer Care

Article

In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients.

But some top oncologists are rethinking that stance, given the soaring costs of new cancer medicines, reduced reimbursement by insurance plans and fresh research that has identified cases where cheaper generic drugs can work just as well - or better - than expensive brand-name medications.

Read the full story:

http://tinyurl.com/d2ltzp2

Source: Reuters

Related Videos
Dr Sundar Jagannath
Senator Vincent Polistina (R, New Jersey)
Senator Vincent Polistina (R, New Jersey)
Jeffrey Fitzgerald, JD
CK Wang, MD, COTA
Eric Lander, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.